Switching to E-Cigarettes and Heated Tobacco Products Reduces Vascular Damage and Smoking-Related Illnesses: Study

Aug.16.2022
Switching to E-Cigarettes and Heated Tobacco Products Reduces Vascular Damage and Smoking-Related Illnesses: Study
CoEHAR researchers found using e-cigarettes and heated tobacco products can reduce smoking-related diseases. Their study challenges misconceptions about vaping.

Researchers from the Center of Excellence for the Acceleration of Harm Reduction (CoEHAR) involved in the Replica project have discovered that switching to electronic cigarettes and heated tobacco products can reduce the incidence of vascular damage and smoking-related diseases. The findings challenge the prevailing misconception that using e-cigarettes and heated tobacco products is just as harmful as smoking.


The study has been published by an independent laboratory affiliated with the Replica Project, whose scientists are world leaders in harm reduction. The latest research assessed the damage caused to endothelial cells, which release substances that control the dilation and contraction of blood vessels, by cigarette smoke compared to electronic cigarettes and heated tobacco products.


Damage to the inner lining of blood vessels known as endothelial damage is a primary pathology that leads to diseases such as atherosclerosis, with smoking being the main culprit. Smoking can impair the normal function of the endothelium, cause damage to the vascular system, and lead to the development of high blood pressure and atherosclerosis. Smoking and exposure to smoke toxins are related to the impairment of the repair mechanism needed for endothelial homeostasis, such as the inhibition of endothelial cell migration.


Reducing exposure to smoke toxins may mitigate the harmful effects on endothelial and cardiovascular disease development. Numerous international studies have investigated the impact of smoking on endothelial cell migration and associated vascular damage, particularly a study by Taylor et al. (2017). Compared to cigarette smoke, exposure to electronic cigarette aerosol significantly reduces inhibition of in vitro (in a test tube) endothelial cell migration. This means that endothelial cells exposed to electronic cigarette aerosol retain their ability to effectively heal small wounds in blood vessels, unlike those exposed to cigarette smoke and toxins, which severely limit their wound repair capacity.


One of CoEHAR's most successful projects is the Replica project, in which researchers have replicated some of the most significant international studies in the field of reducing tobacco harm via an independent laboratory network. They have demonstrated a reduction in the toxicity of electronic cigarettes and have established reference standards for scientific research. The goal of CoEHAR's scientists is to conduct a multicenter replication study to validate the results of Taylor and his colleagues.


A study titled "Comparative evaluation of e-cigarette aerosol and cigarette smoke on endothelial cell migration: a replication study" compared the effects of three commercial e-cigarette delivery systems and traditional cigarettes. Following international scientific standards and utilizing the latest technology and tools, the data collected by researchers at CoEHAR confirmed the findings of Taylor and colleagues: e-cigarettes do not induce inhibition of endothelial cell migration in vitro compared to cigarette smoke, thus reducing harm caused by tobacco smoke. Furthermore, CoEHAR researchers compared the results of two different heated tobacco products, which demonstrated significantly less impact than observed with cigarette smoke.


According to Professor Massimo Caruso, co-project leader of the Replica initiative, "As previously demonstrated by the Replica research team, the harm caused by electronic nicotine delivery systems is significantly lower than the harm caused by cigarette smoke. An interesting fact is that using non-combustible products can reduce vascular damage and prevent the likelihood of smoking-related diseases such as atherosclerosis and hypertension. Our research once again challenges the notion that electronic cigarettes or heated tobacco will cause similar damage to combustible cigarettes.


Statement:


This article is compiled from third-party information and is only meant for industry-related communication and learning purposes.


This article does not represent the views of 2FIRSTS and 2FIRSTS cannot confirm the truthfulness and accuracy of its content. The translation of this article is only intended for industry exchange and research.


Due to limitations in the translation process, the translated article may not fully reflect the original expression. Therefore, please refer to the original article for accuracy.


2FIRSTS is fully aligned with the Chinese government on any domestic, Hong Kong, Macau, Taiwan, and foreign-related statements and positions.


The compilation of information is subject to the copyright ownership of the original media outlet and author. If there is any infringement, please contact us to request removal.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Pennsylvania Vape Directory Law Survives Court Challenge From Nova Distro and Others Amid Similar Rulings Across States
Pennsylvania Vape Directory Law Survives Court Challenge From Nova Distro and Others Amid Similar Rulings Across States
A U.S. federal court upheld Pennsylvania's vape directory law on October 14, rejecting a challenge brought by Nova Distro, 101 Distributors and companies operating Tobacco Hut retail stores. Court records show that vaping accounts for about 60% of Tobacco Hut's profits and that the chain held approximately $2 million in inventory potentially subject to seizure under the law as of June 2. Pennsylvania began enforcement on October 19. The ruling follows similar appellate decisions in other states, even as new research shows that unlisted vaping products continue to account for substantial sales in states with established directories.
Regulations
Oct.22
NAS 2026 | Former FDA Tobacco Chief Mitch Zeller Calls for Shift From “End Game” to “End State”
NAS 2026 | Former FDA Tobacco Chief Mitch Zeller Calls for Shift From “End Game” to “End State”
At the 2026 New Approaches Summit in New York, former FDA Center for Tobacco Products Director Mitch Zeller called for the tobacco harm reduction debate to shift from the traditional “end game” toward defining a desired “end state.” He also highlighted unresolved concerns around dual use, argued that biomarkers of exposure may be more meaningful than cigarettes-per-day in assessing risk reduction, and said nicotine misperceptions remain a major barrier to public health progress.
Sep.25
Swedish-Founded Nicotine Pouch Retailer GotPouches Shifts to U.S.-Based Operations, Reaching Over 25 States
Swedish-Founded Nicotine Pouch Retailer GotPouches Shifts to U.S.-Based Operations, Reaching Over 25 States
Swedish-founded online nicotine pouch retailer GotPouches has completed the localization of its U.S. operations under UpNorth Retail LLC, with corporate operations in Franklin, Tennessee, domestic fulfillment from Nashville and U.S.-based customer support. The company says its catalog covers more than 20 nicotine pouch brands and it currently serves customers in more than 25 U.S. states.
Sep.18
FDA Unifies Tobacco Registration and Product Listing Form Across Product Categories
FDA Unifies Tobacco Registration and Product Listing Form Across Product Categories
The U.S. FDA has consolidated two tobacco establishment registration and product listing forms into a redesigned Form FDA 3741 covering all regulated product categories, including e-cigarettes, heated tobacco products and nicotine pouches. The current requirements remain limited to domestic establishments. Separately, the FDA has proposed extending registration and product listing requirements to foreign manufacturers, signaling greater regulatory attention to manufacturing entities and product-level information across the tobacco and nicotine supply chain.
FDA
Sep.30
Special report|Indonesia's Vape Industry Has 200 Manufacturers and $1.7 Billion in Investment. Could a Regulatory Divide Derail Its Rise as the World's No. 2 Manufacturing Hub After Shenzhen?
Special report|Indonesia's Vape Industry Has 200 Manufacturers and $1.7 Billion in Investment. Could a Regulatory Divide Derail Its Rise as the World's No. 2 Manufacturing Hub After Shenzhen?
Indonesia's Ministry of Industry said at a November 3, 2026, policy forum that the country has about 200 electronic cigarette companies, Rp31 trillion (approximately $1.71 billion) in cumulative industry investment and around 100,000 jobs across the supply chain. The National Narcotics Agency is seeking a comprehensive ban on vape use and circulation, while the industry ministry favors tighter import, product-standard and distribution controls. Indonesia exported approximately $518 million in vaping products in 2025, and Chinese manufacturers including Smoore, GEEKVAPE and Jinjia Group have established local operations. An international logistics specialist interviewed by 2Firsts said more Chinese vape companies began production in Indonesia from the second half of 2025, accompanied by increased shipments of manufacturing equipment and investment in logistics facilities. The regulatory debate comes as Indonesia expands its role in international vaping manufacturing.
Special Report
Nov.05
UK Vape Duty Starts in October as Hayati, DOJO and Others Launch Lower-Capacity Products With Lower Per-Unit Tax
UK Vape Duty Starts in October as Hayati, DOJO and Others Launch Lower-Capacity Products With Lower Per-Unit Tax
The UK's Vaping Products Duty will take effect on October 1, 2026, at a flat rate of £2.20 per 10ml of vaping liquid. Ahead of implementation, DOJO, PIXL and Hayati have introduced or been reported to be adding lower-capacity tiers alongside larger products. DOJO has added a 6ml BLAST7K Fresh below its 10ml BLAST10K Fresh, PIXL offers both a 12ml 8000 and a 6ml 5K, while retailer Ninja Vapes says Hayati is preparing a 7ml 4K alongside its existing 12ml 6K. The pattern points to a growing lower-capacity tier in the UK market, although the brands have not all explicitly linked the changes to the new duty.
Sep.23